全文获取类型
收费全文 | 63708篇 |
免费 | 4665篇 |
国内免费 | 1396篇 |
专业分类
耳鼻咽喉 | 472篇 |
儿科学 | 1089篇 |
妇产科学 | 1590篇 |
基础医学 | 6344篇 |
口腔科学 | 1097篇 |
临床医学 | 9663篇 |
内科学 | 8439篇 |
皮肤病学 | 483篇 |
神经病学 | 2752篇 |
特种医学 | 2276篇 |
外国民族医学 | 12篇 |
外科学 | 5648篇 |
综合类 | 9001篇 |
现状与发展 | 7篇 |
预防医学 | 8962篇 |
眼科学 | 508篇 |
药学 | 6486篇 |
114篇 | |
中国医学 | 2103篇 |
肿瘤学 | 2723篇 |
出版年
2023年 | 1231篇 |
2022年 | 2456篇 |
2021年 | 3692篇 |
2020年 | 2960篇 |
2019年 | 2553篇 |
2018年 | 2116篇 |
2017年 | 2235篇 |
2016年 | 2214篇 |
2015年 | 2066篇 |
2014年 | 4068篇 |
2013年 | 4215篇 |
2012年 | 3777篇 |
2011年 | 4022篇 |
2010年 | 3050篇 |
2009年 | 2841篇 |
2008年 | 2779篇 |
2007年 | 2817篇 |
2006年 | 2288篇 |
2005年 | 2071篇 |
2004年 | 1757篇 |
2003年 | 1514篇 |
2002年 | 1368篇 |
2001年 | 1186篇 |
2000年 | 971篇 |
1999年 | 916篇 |
1998年 | 757篇 |
1997年 | 737篇 |
1996年 | 646篇 |
1995年 | 608篇 |
1994年 | 603篇 |
1993年 | 441篇 |
1992年 | 484篇 |
1991年 | 444篇 |
1990年 | 387篇 |
1989年 | 363篇 |
1988年 | 321篇 |
1987年 | 275篇 |
1986年 | 228篇 |
1985年 | 329篇 |
1984年 | 284篇 |
1983年 | 194篇 |
1982年 | 223篇 |
1981年 | 201篇 |
1980年 | 182篇 |
1979年 | 153篇 |
1978年 | 112篇 |
1977年 | 97篇 |
1976年 | 94篇 |
1975年 | 97篇 |
1974年 | 69篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
Background: Breast cancer (BC) is the most common malignant tumor in women, and its morbidity and mortality are
increasing each year, due to the lack of specific clinical symptoms in the early stage of BC, and the lack of diagnostic
methods for early breast cancer. Therefore, identifying an effective diagnostic method for early BC has become urgent.
Materials and Methods: Breast lesions with a histological diagnosis that were examined by ultrasonic elastography
(UE) in our department from June 2020 to December 2021 were reviewed. qRT-PCR was performed to measure
the expression levels of miR-144-5p and miR-26b-5p in the plasma of patients with BC. The receiver operating characteristics (ROC) curve and area under the curve (AUC) were used to investigate the potential diagnostic value of miR-
144-5p, miR-26b-5p and the elastographic score in BC. Results: The ultrasonic elastography score(UES) was found to
be significantly upregulated in BC compared with that in benign breast lesions, and the AUC, sensitivity and specificity
were 0.809, 0.717 and 0.806 for distinguishing BC from benign breast lesions, respectively. miR-144-5p and miR-26b-
5p were found to be upregulated in the plasma of BC patients, and miR-144-5p+miR-26b-5p had 0.781 sensitivity and
0.780 specificity for the diagnosis of BC. Furthermore, we found that the diagnostic performance of miR-144-5p and
miR-26b-5p combined with UES for BC had 0.913 sensitivity and 0.890 specificity. Conclusions: The combination of
plasma miR-144-5p, miR-26b-5p and UES has a very high clinical application value for the early detection of BC. 相似文献
3.
4.
5.
6.
7.
8.
9.
10.
《Vaccine》2022,40(44):6431-6444
This is a Brighton Collaboration case definition of thrombosis and thromboembolism to be used in the evaluation of adverse events following immunization, and for epidemiologic studies for the assessment of background incidence or hypothesis testing. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of SARS-CoV-2 vaccines. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected expert reviewers prior to submission. 相似文献